1.
Przegl Lek
; 45(4): 412-5, 1988.
Artigo
em Polonês
| MEDLINE
| ID: mdl-3212206
2.
Med Dosw Mikrobiol
; 40(3): 161-6, 1988.
Artigo
em Polonês
| MEDLINE
| ID: mdl-3073280
Assuntos
Candida albicans/patogenicidade , Candidíase/microbiologia , Infecções Oportunistas/microbiologia , Leucemia-Linfoma Linfoblástico de Células Precursoras/microbiologia , Candida albicans/classificação , Candidíase/etiologia , Criança , Humanos , Tolerância Imunológica , Infecções Oportunistas/etiologia , Leucemia-Linfoma Linfoblástico de Células Precursoras/complicações , Leucemia-Linfoma Linfoblástico de Células Precursoras/imunologia , Sorotipagem
3.
Folia Haematol Int Mag Klin Morphol Blutforsch
; 114(6): 789-96, 1987.
Artigo
em Inglês
| MEDLINE
| ID: mdl-2453408
RESUMO
In 82 children affected with Hodgkin's disease, in whom a complete remission was obtained, the first relapses occurred in 13 patients, their outcome was a follows: one child died of relapse and in 12 others second complete remissions were achieved. They were durable in 10 children (median, 65.5 months). Two remaining children had further relapses, their treatment consisted of four successive salvage chemotherapies. Both patients are now in their fifth complete remission. The third-line chemotherapy was already introduced 78+ months and 39+ months ago respectively. We believe that it is not possible to determine exactly the end-stage of Hodgkin's disease in those children and adolescents who have failed the first-line salvage chemotherapy.